Feed NTI.AX
NT
Neurotech International Limited
NTI.AX · ASX
$0.01 +7.69% (+$0.00)
1M -12.50%
Market Cap $13.1M
P/E Ratio -
Div. Yield -
ROE 160.18%
Valuation
38 /100
Fair P/B 4.45x
P/S 5.37x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 27.37%
Rev. growth 299.76%
FCF growth N/A
Profitability
20 /100
Weak Net margin 433.60%
Op. margin 453.62%
FCF margin 369.18%
Quality
9 /100
Poor ROE 160.18%
ROA 327.10%
Asset turnover 0.75x
Debt
100 /100
Low Current ratio 11.34x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
1 /100
Unstable Rev. volatility 71,879.22%
EPS volatility 79.29%
Profitable years 0
Întreabă StockBot despre NTI.AX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Anthony Filippis
Employees
18
Headquarters
Melbourne
Evenimente viitoare
02 SEPT.
Earnings
Upcoming earnings report